340 related articles for article (PubMed ID: 36053748)
1. Gender-affirming estrogen therapy route of administration and cardiovascular risk: a systematic review and narrative synthesis.
Turino Miranda K; Kalenga CZ; Saad N; Dumanski SM; Collister D; Rytz CL; Lorenzetti DL; Chang DH; McClurg C; Sola DY; Ahmed SB
Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H861-H868. PubMed ID: 36053748
[TBL] [Abstract][Full Text] [Related]
2. Association between Serum Estradiol and Cardiovascular Health among Transgender Adults Using Gender-Affirming Estrogen Therapy.
Rytz CL; Turino Miranda K; Ronksley PE; Saad N; Raj SR; Somayaji R; Dumanski SM; Ganshorn H; Greene DN; Collister D; Newbert AM; Peace L; Ahmed SB
Am J Physiol Heart Circ Physiol; 2024 Apr; ():. PubMed ID: 38578239
[TBL] [Abstract][Full Text] [Related]
3. Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review.
Spanos C; Bretherton I; Zajac JD; Cheung AS
World J Diabetes; 2020 Mar; 11(3):66-77. PubMed ID: 32180895
[TBL] [Abstract][Full Text] [Related]
4. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
Cocchetti C; Castellini G; Iacuaniello D; Romani A; Maggi M; Vignozzi L; Schreiner T; den Heijer M; T'Sjoen G; Fisher AD
J Sex Med; 2021 Apr; 18(4):821-829. PubMed ID: 33745831
[TBL] [Abstract][Full Text] [Related]
5. Serum oestradiol levels and risk of adverse cardiovascular events associated with gender-affirming oestrogen therapy: a protocol for a systematic review and meta-analysis.
Rytz CL; Turino Miranda K; Ronksley PE; Dumanski SM; Saad N; Raj SR; Somayaji R; Ganshorn H; Newbert AM; Peace L; Ahmed SB
BMJ Open; 2022 Nov; 12(11):e064961. PubMed ID: 36328386
[TBL] [Abstract][Full Text] [Related]
6. Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in Transwomen.
van Velzen DM; Paldino A; Klaver M; Nota NM; Defreyne J; Hovingh GK; Thijs A; Simsek S; T'Sjoen G; den Heijer M
J Clin Endocrinol Metab; 2019 Jun; 104(6):1937-1947. PubMed ID: 30602016
[TBL] [Abstract][Full Text] [Related]
7. Health Outcomes Associated With Having an Oophorectomy Versus Retaining One's Ovaries for Transmasculine and Gender Diverse Individuals Treated With Testosterone Therapy: A Systematic Review.
Kumar S; Mukherjee S; O'Dwyer C; Wassersug R; Bertin E; Mehra N; Dahl M; Genoway K; Kavanagh AG
Sex Med Rev; 2022 Oct; 10(4):636-647. PubMed ID: 37051961
[TBL] [Abstract][Full Text] [Related]
8. Health Outcomes Associated With Having an Oophorectomy Versus Retaining One's Ovaries for Transmasculine and Gender Diverse Individuals Treated With Testosterone Therapy: A Systematic Review.
Kumar S; Mukherjee S; O'Dwyer C; Wassersug R; Bertin E; Mehra N; Dahl M; Genoway K; Kavanagh AG
Sex Med Rev; 2022 Oct; 10(4):636-647. PubMed ID: 35831234
[TBL] [Abstract][Full Text] [Related]
9. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review.
Oliver-Williams C; Glisic M; Shahzad S; Brown E; Pellegrino Baena C; Chadni M; Chowdhury R; Franco OH; Muka T
Hum Reprod Update; 2019 Mar; 25(2):257-271. PubMed ID: 30508190
[TBL] [Abstract][Full Text] [Related]
10. Lipid profile and risk of cardiovascular disease in adult transgender men receiving cross-sex hormone therapy: a systematic review.
Quintela-Castro FCA; Pereira TSS; Alves DB; Chiepe L; Nascimento LS; Chiepe KCMB; Barcelos RM; Costa BM; Enriquez-Martinez OG; Rossoni JV; Bellettini-Santos T
Nutr Rev; 2023 Sep; 81(10):1310-1320. PubMed ID: 36779324
[TBL] [Abstract][Full Text] [Related]
11. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
[TBL] [Abstract][Full Text] [Related]
12. Associations of oral contraceptive use with serum lipids and lipoproteins in young women: the Bogalusa Heart Study.
Greenlund KJ; Webber LS; Srinivasan S; Wattigney W; Johnson C; Berenson GS
Ann Epidemiol; 1997 Nov; 7(8):561-7. PubMed ID: 9408552
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular Risk in Transgender People With Gender-Affirming Hormone Treatment.
Masumori N; Nakatsuka M
Circ Rep; 2023 Apr; 5(4):105-113. PubMed ID: 37025940
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review.
Moreira Allgayer RMC; Borba GDS; Moraes RS; Ramos RB; Spritzer PM
Endocr Pract; 2023 Jun; 29(6):498-507. PubMed ID: 36603652
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Gender-Affirming Hormone Therapy and Cognitive Functioning in Older Transgender Women Compared With Cisgender Women and Men.
van Heesewijk JO; Dreijerink KMA; Wiepjes CM; Kok AAL; van Schoor NM; Huisman M; den Heijer M; Kreukels BPC
J Sex Med; 2021 Aug; 18(8):1434-1443. PubMed ID: 34247950
[TBL] [Abstract][Full Text] [Related]
16. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
[TBL] [Abstract][Full Text] [Related]
17. Effects of Gender-Affirming Hormones on Lipid, Metabolic, and Cardiac Surrogate Blood Markers in Transgender Persons.
Defreyne J; Van de Bruaene LDL; Rietzschel E; Van Schuylenbergh J; T'Sjoen GGR
Clin Chem; 2019 Jan; 65(1):119-134. PubMed ID: 30602477
[TBL] [Abstract][Full Text] [Related]
18. Changes in Blood Lipids Following Initiation of Gender Affirming Hormone Therapy: A Systematic Review and Meta-Analysis.
Gosiker B; Moutchia J; Nguyen N; Getahun D; Goodman M
J Clin Transl Endocrinol; 2024 Jun; 36():100349. PubMed ID: 38737626
[TBL] [Abstract][Full Text] [Related]
19. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
LaRosa JC
Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
